Results 161 to 170 of about 5,456,142 (288)
Low Steatosis May Signal Failing Reserve in Cirrhosis due to Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]
Li H.
europepmc +1 more source
Phosphatidylethanol in the Management of Steatotic Liver Disease
Baggrund: Steatotisk leversygdom (SLD) dækker over et spektrum af tilstande med ophobning af lipider i hepatocytter, herunder metabolisk dysfunktion-associeret steatotisk leversygdom (MASLD), alkoholrelateret leversygdom (ALD) og den nyligt definerede fænotype metabolisk og alkohol-relateret leversygdom (MetALD).
openaire +2 more sources
The Bidirectional Association Between MASLD and Male Hypogonadism: An Updated Meta‐Analysis
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) and male hypogonadism are increasingly prevalent, metabolically interrelated conditions. Testosterone (T) deficiency has been implicated in hepatic lipid dysregulation, insulin resistance, and visceral adiposity, whereas MASLD may impair the hypothalamic–pituitary ...
Giorgia Spaggiari +9 more
wiley +1 more source
Is glucagon action altered in steatotic liver disease? [PDF]
Mirmira RG.
europepmc +1 more source
Impact of Single Viable Hepatocellular Carcinoma ≤ 3 cm on Survival After Liver Transplantation
An Australian multi‐centre cohort study shows significantly lower 5‐year HCC‐specific mortality for those with no viable disease compared to those with a single viable tumour ≤ 3 cm, on imaging prior to transplantation. A lower AFP level and complete response on mRECIST criteria also reduced risk.
Lauren C. Y. Tang +12 more
wiley +1 more source
Response to Letter to the Editor "Sleep hygiene in pediatric patients with steatotic liver disease". [PDF]
Ozkan B, Akbulut UE.
europepmc +1 more source
Analysis of 4928 normothermic machine perfusion liver transplants reveals that recipient factors, particularly MELD ≥ 35, surgical complexity, ICU status, and functional impairment are stronger predictors of graft failure than donor characteristics, emphasizing the continued importance of clinical judgment in patient selection.
Lauren E. Matevish +9 more
wiley +1 more source
Metabolic Dysfunction-Associated Steatotic Liver Disease: An Underrated and Emerging Cardiovascular Risk Factor. [PDF]
Sabouret P +12 more
europepmc +1 more source
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala +13 more
wiley +1 more source

